ForViva (LON:FVA – Get Free Report)‘s stock had its “hold” rating restated by Shore Capital Group in a research note issued to investors on Wednesday, Digital Look reports. They presently have a GBX 135 price target on the stock. Shore Capital Group’s target price suggests a potential downside of 6.57% from the company’s current price.
Separately, Canaccord Genuity Group reiterated a “buy” rating and set a GBX 190 price target on shares of ForViva in a research note on Friday, August 14th. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 162.50.
Read Our Latest Research Report on FVA
ForViva Stock Down 3.7%
Insider Buying and Selling
In related news, insider Tim Jones acquired 40,000 shares of the stock in a transaction on Friday, July 17th. The stock was purchased at an average price of GBX 138 per share, for a total transaction of £55,200. Over the last 90 days, insiders have bought 90,000 shares of company stock worth $12,380,000. 7.31% of the stock is owned by corporate insiders.
ForViva Company Profile
ForViva plc (LON: FVA) is a United Kingdom–based property company that operates in the residential and specialist housing sectors. The group’s activities are focused on ownership, management and leasing of housing assets that serve social, affordable and supported living needs. Its portfolio is oriented toward providing long‑term rental accommodation and specialist premises that accommodate people requiring additional care or support.
Services associated with ForViva’s property portfolio typically include day‑to‑day asset management, tenancy management, property maintenance and refurbishment, and collaboration with public sector bodies and third‑party care providers to deliver supported housing solutions.
Featured Articles
- Five stocks we like better than ForViva
- 3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury Note
- 3 AI Winners, 3 Very Different Paths to Higher Margins
- Plexus Is Booming—But Can the Growth Story Last?
- Conagra’s Turnaround Is Starting to Show Up in the Numbers
Receive News & Ratings for ForViva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ForViva and related companies with MarketBeat.com's FREE daily email newsletter.
